Clinical Features of Central Nervous System Complications Caused by the SARS‐CoV‐2 Omicron Variant

Documenti analoghi

• Risk of intensive care unit admission and mortality in patients hospitalized due to influenza A or B and SARS‑CoV‑2 variants Omicron or Delta
  di: Omid Rezahosseini, et al.
  Pubblicazione: (2024)
• Presence of neutralizing SARS‐CoV‐2 antibodies in asymptomatic population of N'Djamena, Chad
  di: Andrillene Laure Deutou Wondeu, et al.
  Pubblicazione: (2024)
• Evaluation of self‐collected nasal, urine, and saliva samples for molecular detection of SARS‐CoV‐2 using an EUA approved RT‐PCR assay and a laboratory developed LAMP SARS‐CoV‐2 test
  di: Ana Purcell‐Wiltz, et al.
  Pubblicazione: (2024)
• A community based seroprevalence of SARS‐CoV‐2 antibodies in Somali Region, Eastern Ethiopia
  di: Solomon Yared, et al.
  Pubblicazione: (2024)
• Seroprevalence of SARS‐CoV‐2 Antibody Before and After Both Vaccination and Natural Infection in China
  di: Yang Guang, et al.
  Pubblicazione: (2025)